AI assistant
Sending…
Bolt Biotherapeutics, Inc. — Director's Dealing 2021
Feb 4, 2021
35210_dirs_2021-02-04_b8e9f563-f31f-43e7-b2a8-b6a490c9fcc0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-02-04
Reporting Person: Moldt Peter (Director)
More from Bolt Biotherapeutics, Inc.
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16